ACTBL1 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the ACTBL1 (Beta-Actin-Like Protein 1) protein. ACTBL1 is part of the actin protein family, which plays a critical role in various cellular functions such as maintaining the cytoskeleton structure, regulating cell motility, and facilitating intracellular transport. ACTBL1 shares structural similarities with beta-actin, and it is involved in organizing the actin cytoskeleton and mediating dynamic processes within the cell. Inhibitors of ACTBL1 are typically designed to disrupt the polymerization of actin filaments or to block protein-protein interactions required for actin filament assembly and stabilization. These inhibitors bind to key regions of the ACTBL1 protein, such as its ATP-binding site or actin-binding domains, preventing the normal actin filament formation and function.
The development of ACTBL1 inhibitors involves detailed structural studies of the protein, including its three-dimensional conformation and active binding sites, often using techniques like X-ray crystallography or cryo-electron microscopy. Understanding the structural features of ACTBL1 allows researchers to design inhibitors that interact specifically with the protein's functional domains, such as regions involved in ATP hydrolysis or binding to other actin-associated proteins. Computational methods such as molecular docking and molecular dynamics simulations are frequently employed to model how inhibitors interact with ACTBL1, allowing for the optimization of binding affinity and specificity. Additionally, some ACTBL1 inhibitors may work through allosteric mechanisms, binding to non-catalytic regions of the protein and inducing conformational changes that inhibit its activity. By inhibiting ACTBL1, these compounds serve as valuable tools for exploring the role of actin-like proteins in cytoskeletal dynamics and for understanding the broader implications of actin filament regulation in cellular processes such as motility, division, and intracellular transport.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Disrupts actin polymerization, potentially affecting processes involving ACTBL1. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Binds to actin monomers, inhibiting polymerization, possibly impacting ACTBL1 function. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments, could indirectly affect ACTBL1 through altered actin dynamics. | ||||||
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $234.00 | 33 | |
Stabilizes actin filaments, may influence cell morphology and movement processes involving ACTBL1. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Inhibits myosin II, affecting muscle contraction and cell motility, potentially related to ACTBL1. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Rho kinase inhibitor, impacts actin cytoskeleton dynamics, possibly affecting ACTBL1. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
Arp2/3 complex inhibitor, affecting actin nucleation, potentially impacting ACTBL1 activity. | ||||||
SMIFH2 | 340316-62-3 | sc-507273 | 5 mg | $140.00 | ||
Inhibits formin-mediated actin assembly, possibly influencing pathways involving ACTBL1. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Inhibits myosin light chain kinase, potentially affecting actin-myosin interactions and ACTBL1. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Disrupts microtubule polymerization, indirectly influencing actin dynamics and potentially ACTBL1. | ||||||